Spero Therapeutics, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Spero Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-12-31 was $0.00.
- Spero Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-09-30 was $2.00K.
- Spero Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-06-30 was $1.00K.
- Spero Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $3.00K.
- Spero Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2017 was $107.02M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $3.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $2.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $1.00K 10-Q · filed 2023-08-10 | |
| 2017-12-31 | $107.02M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |